Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.86 USD | -3.65% | +3.00% | -12.39% |
May. 09 | Transcript : LifeStance Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | LifeStance Health Q1 Loss Narrows as Revenue Increases; 2024 Revenue Outlook Reiterated | MT |
Summary
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.39% | 2.62B | D+ | ||
+20.68% | 85.55B | C+ | ||
-29.31% | 70.07B | B- | ||
+9.23% | 28.95B | C+ | ||
-8.63% | 17.51B | B | ||
+2.14% | 17.39B | A- | ||
+0.39% | 15.38B | A- | ||
+6.47% | 13.4B | B- | ||
+68.09% | 12.93B | C- | ||
+6.43% | 12.77B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LFST Stock
- Ratings LifeStance Health Group, Inc.